Related Experiment Video
Updated: Jan 20, 2026

Simple and Fast Rolling Circle Amplification-Based Detection of Topoisomerase 1 Activity in Crude Biological Samples
Published on: December 2, 2022
Topoisomerase inhibitors promote cancer cell motility via ROS-mediated activation of JAK2-STAT1-CXCL1 pathway
Jiafei Liu1, Like Qu1, Lin Meng1
1Key laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Biochemistry and Molecular Biology, Peking University Cancer Hospital and Institute, 52 Fucheng Road, Beijing, 100142, China.
Background:
Topoisomerase inhibitors (TI) can inhibit cell proliferation by preventing DNA replication, stimulating DNA damage and inducing cell cycle arrest. Although these agents have been commonly used in the chemotherapy for the anti-proliferative effect, their impacts on the metastasis of cancer cells remain obscure.
Methods:
We used the transwell chamber assay to test effects of Topoisomerase inhibitors Etoposide (VP-16), Adriamycin (ADM) and Irinotecan (CPT-11) on the migration and invasion of cancer cells. Conditioned medium (CM) from TI-treated cells was subjected to Mass spectrometry screening. Gene silencing, neutralizing antibody, and specific chemical inhibitors were used to validate the roles of signaling molecules.
Results:
Our studies disclosed that TI could promote the migration and invasion of a subset of cancer cells, which were dependent on chemokine (C-X-C motif) ligand 1 (CXCL1). Further studies disclosed that TI enhanced phosphorylation of Janus kinase 2 (JAK2) and Signal transducers and activators of transcription 1 (STAT1). Silencing or chemical inhibition of JAK2 or STAT1 abrogated TI-induced CXCL1 expression and cell motility. Moreover, TI increased cellular levels of reactive oxygen species (ROS) and promoted oxidation of Protein Tyrosine Phosphatase 1B (PTP1B), while reduced glutathione (GSH) reversed TI-induced JAK2-STAT1 activation, CXCL1 expression, and cell motility.
Conclusions:
Our study demonstrates that TI can promote the expression and secretion of CXCL1 by elevating ROS, inactivating PTP1B, and activating JAK2-STAT1 signaling pathway, thereby promoting the motility of cancer cells.
Insights
Topoisomerase inhibitors (TI) promote cancer cell migration and invasion by increasing CXCL1 expression. This process involves reactive oxygen species (ROS), Protein Tyrosine Phosphatase 1B (PTP1B) inactivation, and JAK2-STAT1 pathway activation.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Topoisomerase inhibitors (TI) are used in chemotherapy for their anti-proliferative effects.
- The impact of TI on cancer cell metastasis remains largely unknown.
Purpose of the Study:
- To investigate the effects of TI on cancer cell migration and invasion.
- To elucidate the molecular mechanisms underlying TI-induced cancer cell motility.
Main Methods:
- Transwell chamber assays were used to assess cancer cell migration and invasion.
- Mass spectrometry was employed to analyze conditioned medium from TI-treated cells.
- Gene silencing, neutralizing antibodies, and chemical inhibitors were utilized to validate signaling pathways.
Main Results:
- TI were found to enhance the migration and invasion of certain cancer cells, dependent on CXCL1.
- TI treatment increased Janus kinase 2 (JAK2) and Signal transducers and activators of transcription 1 (STAT1) phosphorylation.
- Reactive oxygen species (ROS) elevation and Protein Tyrosine Phosphatase 1B (PTP1B) oxidation were observed, while glutathione (GSH) reversed these effects.
Conclusions:
- TI promote cancer cell motility by upregulating CXCL1 expression and secretion.
- This promotion is mediated by increased ROS, inactivated PTP1B, and activated JAK2-STAT1 signaling.
- These findings reveal a novel mechanism by which TI can influence cancer metastasis.
More Related Videos
08:49Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
05:21Author Spotlight: Optimizing Antibody-Based Cancer Treatments via Antibody-Dependent, Cell-Mediated Cytotoxicity Assay
Published on: September 13, 2024
Related Concept Videos
DNA Topoisomerases
Types and Mechanism of action
Topoisomerases are divided into two main types. ...
Microtubules in Cell Motility
Cell Motility through Blebbing
Blebbing Through the Matrix
In multicellular...
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
The Eukaryotic Promoter Region
Actin Polymerization and Cell Motility
Actin cytoskeleton dynamics can produce pushing, pulling, and resistance forces that help the cell to migrate....